Cathie Wood's ARK ETF published their daily trades for Thursday, September 5th, 2024, revealing a series of strategic moves in the tech and healthcare sectors. Leading the day's transactions was a significant purchase of PAGERDUTY INC (NYSE:PD) shares, with ARK acquiring a total of 325,939 shares across its ARKK and ARKW ETFs, amounting to a dollar value of approximately $5.89 million.
In contrast, ARK offloaded a substantial number of UIPATH INC (NYSE:PATH) shares, divesting a total of 658,219 shares through its ARKK and ARKW ETFs, which equated to a value of over $8.37 million. This move comes as the largest dollar-value trade of the day, underscoring a potential shift in ARK's investment strategy or a response to market dynamics.
The firm's trading activity also included selling 48,901 shares of TWIST BIOSCIENCE CORP (NASDAQ:TWST) for around $1.93 million and 28,011 shares of VERACYTE INC (NASDAQ:VCYT) valued at approximately $827,725. Both transactions were executed through the ARKK ETF.
Additionally, ARK continued to build its position in RECURSION PHARMACEUTICALS INC (NASDAQ:RXRX), purchasing 205,927 shares across its ARKK and ARKG ETFs, with a total dollar value of about $1.26 million. This buying pattern aligns with ARK's previous trades, indicating a growing interest in the pharmaceutical company.
Smaller-scale sales were also part of ARK's daily trading activity, including divesting 10,158 shares of CAREDX INC (NASDAQ:CDNA) for $281,173 and 10,696 shares of 908 DEVICES INC. (NASDAQ:MASS) at a value of $39,896, both through the ARKG ETF. Additionally, ARK sold 1,404 shares of MATERIALISE NV (NASDAQ:MTLS) for $7,090 via its ARKQ ETF, and a minor sale of 52 shares of VERVE THERAPEUTICS INC (NASDAQ:VERV) at $317 through the ARKG ETF.
The report also noted a sale of 513,606 shares of VUZIX CORP (NASDAQ:VUZI) spread across the ARKQ and ARKW ETFs, totaling $477,653. This follows a pattern of selling activity in VUZI shares observed in previous days.
Investors following Cathie Wood's ARK ETFs will take note of these trades as they reflect the fund's ongoing adjustments to its investment portfolio, possibly indicating broader trends or shifts in focus within the tech and healthcare sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.